13F

Stock

Travere Therapeutics, Inc.

TVTX · held by 2 managers

Reported value

$2.84M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$1.73M

Price effect on 2 books still in the name

Largest holder

$2.58M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC288.7K$2.58M−$1.62MCut−$1.3M
Henshaw Capital LLC29.2K$260.8K−$105.8KAdded$7.57K

Positions as of Q3 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.